Daniel Getts

Daniel Getts

Company: Myeloid Therapeutics

Job title: Chief Executive Officer


Panel Discussion: Reviewing the Past 12 Months of Progress in Understanding Myeloid Populations and their Role in Immunotherapy 9:00 am

With no validated clinical evidence of the effectiveness of a therapeutic targeting the TME, what evidence is available and most to those exploring the potential of a therapeutic in this area? What discoveries have been most revealing over the last 12 months? Based on our current understanding, which therapeutic modality is most likely to be…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.